Skip to main content
SpringerLink
Log in

Pathological Aspects of Hepatocellular Tumors

  • Chapter
Hepatocellular Cancer

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Hepatocellular adenoma (HA) is an uncommon and benign tumor of the liver, seen most often in young women of childbearing age with a history of oral contraceptive use (Table 1) (1). The longer the duration of intake of oral contraceptives, the higher the risk of developing hepatic adenoma (2). Anabolic steroid use also is associated with HA, and an example of this lesion arising in conjunction with growth hormone therapy for Turner’s syndrome has been reported (3). An association of liver cell adenoma and various genetic metabolic disorders (such as glycogen storage diseases types I, III, or IV, galactosemia, tyrosinemia, and, rarely, diabetes mellitus or familial adenomatous polyposis) also has been reported (4–9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173:426–431.

    PubMed  CAS  Google Scholar 

  2. Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 1991;43:643–652.

    Article  PubMed  CAS  Google Scholar 

  3. Espat J, Chamberlain RS, Sklar C, Blumgart LH. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner’s syndrome. Dig Surg 2000;17:640–643.

    Article  PubMed  CAS  Google Scholar 

  4. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001;21:877–892; discussion, 892–894.

    PubMed  CAS  Google Scholar 

  5. Yoshikawa M, Fukui K, Kuriyama S, et al. Hepatic adenomas treated with percutaneous ethanol injection in a patient with glycogen storage disease type Ia. J Gastroenterol 2001;36:52–61.

    Article  PubMed  CAS  Google Scholar 

  6. Alshak NS, Cocjin J, Podesta L, et al. Hepatocellular adenoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994;118:88–91.

    PubMed  CAS  Google Scholar 

  7. Chandra RS, Kapur SP, Kelleher J Jr, Luban N, Patterson K. Benign hepatocellular tumors in the young. A clinicopathologic spectrum. Arch Pathol Lab Med 1984;108:168–171.

    PubMed  CAS  Google Scholar 

  8. Bala S, Wunsch PH, Ballhausen WG. Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. Gastroenterology 1997;112:919–922.

    Article  PubMed  CAS  Google Scholar 

  9. Foster JH, Donohue TA, Berman MM. Familial liver-cell adenomas and diabetes mellitus. N Engl J Med 1978;299:239–241.

    Article  PubMed  CAS  Google Scholar 

  10. Chevallier P, Peten EP, Baldini E, Gugenheim J. Pedunculated hepatic adenoma: sonographic and MR imaging features. AJR Am J Roentgenol 1999;172:1146–1147.

    PubMed  CAS  Google Scholar 

  11. Balci NC, Sirvanci M, Duran C, Akinci A. Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide. Clin Imaging 2002;26:35–38.

    Article  PubMed  Google Scholar 

  12. Iijima H, Moriwaki Y, Yamamoto T, Takahashi S, Nishigami T, Hada T. Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings. Intern Med 2001;40:891–895.

    PubMed  CAS  Google Scholar 

  13. Hung CH, Changchien CS, Lu SN, et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001;26:500–506.

    Article  PubMed  CAS  Google Scholar 

  14. Palmer PE, Christopherson WM, Wolfe HJ. Alpha-1-antitrypsin, protein marker in oral contraceptive-associated hepatic tumors. Am J Clin Pathol 1977;68:736–739.

    PubMed  CAS  Google Scholar 

  15. Poe R, Snover DC. Adenomas in glycogen storage disease type 1. Two cases with unusual histologic features. Am J Surg Pathol 1988;12:477–483.

    PubMed  CAS  Google Scholar 

  16. Heffelfinger S, Irani DR, Finegold MJ. “Alcoholic hepatitis” in a hepatic adenoma. Hum Pathol 1987;18:751–754.

    Article  PubMed  CAS  Google Scholar 

  17. Tao LC. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer 1991;68(2):341–347.

    Article  PubMed  CAS  Google Scholar 

  18. Cohen C, Lawson D, DeRose PB. Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Pathol 1998;29:1428–1432.

    Article  PubMed  CAS  Google Scholar 

  19. Torbenson M, Lee J, Choti M, et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002;15:189–196.

    Article  PubMed  Google Scholar 

  20. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001;25:1388–1396.

    Article  PubMed  CAS  Google Scholar 

  21. Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH. Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001;193:476–482.

    Article  PubMed  CAS  Google Scholar 

  22. Wilkens L, Bredt M, Flemming A, et al. Detection of chromosomal aberrations in well-differentiated hepatocellular carcinoma by bright-field in situ hybridization. Mod Pathol 2002;15:470–475.

    Article  PubMed  Google Scholar 

  23. Reddy KR, Kligerman S, Levi J, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173–178.

    PubMed  CAS  Google Scholar 

  24. Herman P, Pugliese V, Machado MA, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000;24:372–376.

    Article  PubMed  CAS  Google Scholar 

  25. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214:861–868.

    PubMed  CAS  Google Scholar 

  26. Terkivatan T, de Wilt JH, de Man RA, et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001;136:1033–1038.

    Article  PubMed  CAS  Google Scholar 

  27. Closset J, Veys I, Peny MO, et al. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 2000;47:1382–1384.

    PubMed  CAS  Google Scholar 

  28. Aseni P, Sansalone CV, Sammartino C, et al. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 2001;33:234–236.

    Article  PubMed  CAS  Google Scholar 

  29. Steinbrecher UP, Lisbona R, Huang SN, Mishkin S. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 1981;26:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  30. Buhler H, Pirovino M, Akobiantz A, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982;82:775–782.

    PubMed  CAS  Google Scholar 

  31. Heeringa B, Sardi A. Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection. Am Surg 2001;67:927–929.

    PubMed  CAS  Google Scholar 

  32. Trevisani F, Caraceni P, Bernardi M, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993;72:1557–1563.

    Article  PubMed  CAS  Google Scholar 

  33. Eggel H. Uber das primare carcinom der leber. Beitr Pathol Anat 1901;30:506–604.

    Google Scholar 

  34. Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001;182:177–182.

    Article  PubMed  CAS  Google Scholar 

  35. Stroffolini T, Andreone P, Andriulli A, et al. Gross pathologic types of hepatocellular carcinoma in Italy. Oncology 1999;56:189–192.

    Article  PubMed  CAS  Google Scholar 

  36. Horie Y, Katoh S, Yoshida H, Imaoka T, Suou T, Hirayama C. Pedunculated hepatocellular carcinoma. Report of three cases and review of literature. Cancer 1983;51:746–751.

    Article  PubMed  CAS  Google Scholar 

  37. Horie Y, Shigoku A, Tanaka H, et al. Prognosis for pedunculated hepatocellular carcinoma. Oncology 1999;57:23–28.

    Article  PubMed  CAS  Google Scholar 

  38. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225–237.

    Article  PubMed  CAS  Google Scholar 

  39. Nakashima O, Sugihara S, Eguchi A, Taguchi J, Watanabe J, Kojiro M. Pathomorphologic study of pale bodies in hepatocellular carcinoma. Acta Pathol Jpn 1992;42:414–418.

    PubMed  CAS  Google Scholar 

  40. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810–819.

    Article  PubMed  CAS  Google Scholar 

  41. Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990;66:2174–2170.

    Article  PubMed  CAS  Google Scholar 

  42. Albacete RA, Matthews MJ, Saini N. Portal vein thromboses in malignant hepatoma. Ann Intern Med 1967;67:337–348.

    PubMed  CAS  Google Scholar 

  43. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001;91:1479–1486.

    Article  PubMed  CAS  Google Scholar 

  44. Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 2000;191:657–660.

    Article  PubMed  CAS  Google Scholar 

  45. Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 1982;49:2144–2147.

    Article  PubMed  CAS  Google Scholar 

  46. Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med 1984;108:989–992.

    PubMed  CAS  Google Scholar 

  47. Nakashima T, Okuda K, Kojiro M, et al. Pathology of hepatocellular carcinoma in Japan. Two hundred thirty-two consecutive cases autopsied in ten years. Cancer 1983;51:863–877.

    Article  PubMed  CAS  Google Scholar 

  48. Tantawi B, Cherqui D, Tran van Nhieu J, Kracht M, Fagniez PL. Surgery for biliary obstruction by tumour thrombus in primary liver cancer. Br J Surg 1996;83:1522–1525.

    Article  PubMed  CAS  Google Scholar 

  49. Staudacher C, Chiappa A, Biella F, Audisio RA, Bertani E, Zbar AP. Validation of the modified TNM-Izumi classification for hepatocellular carcinoma. Tumori 2000;86:8–11.

    PubMed  CAS  Google Scholar 

  50. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840–845.

    Article  Google Scholar 

  51. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–338.

    PubMed  CAS  Google Scholar 

  52. Leung TW, Tang AM, Zee B, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002;94:1760–1769.

    Article  PubMed  Google Scholar 

  53. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538–543.

    Article  PubMed  CAS  Google Scholar 

  54. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389–394.

    Article  PubMed  CAS  Google Scholar 

  55. Kondo Y. Histologic features of hepatocellular carcinoma and allied disorders. Pathol Ann 1985;20(Pt 2):405–430.

    Google Scholar 

  56. Komatsu T, Kondo Y, Yamamoto Y, Isono K. Hepatocellular carcinoma presenting well differentiated, normotrabecular patterns in peripheral or metastatic loci. Analysis of 103 resected cases. Acta Pathol Jpn 1990;40:887–893.

    PubMed  CAS  Google Scholar 

  57. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986;6:259–266.

    PubMed  CAS  Google Scholar 

  58. Kondo Y, Nakajima T. Pseudoglandular hepatocellular carcinoma. A morphogenetic study. Cancer 1987;60:1032–1037.

    Article  PubMed  CAS  Google Scholar 

  59. Lauwers GY, Terris B, Balis UJ, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002;26:25–34.

    Article  PubMed  Google Scholar 

  60. Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus. J Submicrosc Cytol Pathol 2001;33:195–200.

    PubMed  CAS  Google Scholar 

  61. Yang SH, Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol Int 1996;46:503–509.

    PubMed  CAS  Google Scholar 

  62. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000;33:282–289.

    Article  PubMed  CAS  Google Scholar 

  63. Moon WS, Yu HC, Chung MJ, Kang MJ, Lee DG. Pale bodies in hepatocellular carcinoma. J Korean Med Sci 2000;15:516–520.

    PubMed  CAS  Google Scholar 

  64. Stromeyer FW, Ishak KG, Gerber MA, Mathew T. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 1980;74:254–258.

    PubMed  CAS  Google Scholar 

  65. Nakanuma Y, Kono N, Ohta G, et al. Pale eosinophilic inclusions simulating ground-glass appearance of cells of hepatocellular carcinoma. Acta Pathol Jpn 1982;32:71–81.

    PubMed  CAS  Google Scholar 

  66. Stumptner C, Heid H, Fuchsbichler A, et al. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol 1999;154:1701–1710.

    PubMed  CAS  Google Scholar 

  67. Jensen K, Gluud C. The Mallory body: morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology 1994;20:1061–1077.

    Article  PubMed  CAS  Google Scholar 

  68. Dominguez-Malagon H, Gaytan-Graham S. Hepatocellular carcinoma: an update. Ultrastruct Pathol 2001;25:497–516.

    Article  PubMed  CAS  Google Scholar 

  69. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996;24:807–812.

    Article  PubMed  CAS  Google Scholar 

  70. Tsujimoto T, Kuriyama S, Yamazaki M, et al. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol 2001;18:41–47.

    PubMed  CAS  Google Scholar 

  71. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205–212.

    Article  PubMed  CAS  Google Scholar 

  72. Okuda K, Musha H, Nakajima Y, et al. Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases. Cancer 1977;40:1240–1245.

    Article  PubMed  CAS  Google Scholar 

  73. Torimura T, Ueno T, Inuzuka S, Tanaka M, Abe H, Tanikawa K. Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma. Immunohistochemical study. Arch Pathol Lab Med 1991;115:365–371.

    PubMed  CAS  Google Scholar 

  74. Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 2001;438:574–580.

    Article  PubMed  CAS  Google Scholar 

  75. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503.

    Article  PubMed  CAS  Google Scholar 

  76. Rua S, Comino A, Fruttero A, et al. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Cancer 1996;78:1195–1202.

    Article  PubMed  CAS  Google Scholar 

  77. Oriyama T, Yamanaka N, Fujimoto J, Ichikawa N, Okamoto E. Progression of hepatocellular carcinoma as reflected by nuclear DNA ploidy and cellular differentiation. J Hepatol 1998;28:142–149.

    Article  PubMed  CAS  Google Scholar 

  78. Tannapfel A, Wasner M, Krause K, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999;91:1154–1158.

    Article  PubMed  CAS  Google Scholar 

  79. Kirimlioglu H, Dvorchick I, Ruppert K, et al. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology 2001;34:502–510.

    Article  PubMed  CAS  Google Scholar 

  80. Saito Y, Matsuzaki Y, Doi M, et al. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameter. J Gastroenterol 1998;33:229–235.

    Article  PubMed  CAS  Google Scholar 

  81. Nolte M, Werner M, Nasarek A, et al. Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis. J Clin Pathol 1998;51:47–51.

    PubMed  CAS  Google Scholar 

  82. Tanigawa N, Lu C, Mitsui T, Miura S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997;26:1216–1223.

    PubMed  CAS  Google Scholar 

  83. El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998;27:1554–1562.

    Article  PubMed  CAS  Google Scholar 

  84. Ker CG, Chen HY, Juan CC, et al. Role of angiogenesis in hepatitis and hepatocellular carcinoma. Hepatogastroenterology 1999;46:646–650.

    PubMed  CAS  Google Scholar 

  85. Kimura H, Nakajima T, Kagawa K, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998;18:14–19.

    PubMed  CAS  Google Scholar 

  86. Minervini MI, Demetris AJ, Lee RG, Carr BI, Madariaga J, Nalesnik MA. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686–692.

    PubMed  CAS  Google Scholar 

  87. Brumm C, Schulze C, Charels K, Morohoshi T, Kloppel G. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology 1989;14:503–513.

    Article  PubMed  CAS  Google Scholar 

  88. Hurlimann J, Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 1991;15:280–288.

    PubMed  CAS  Google Scholar 

  89. Ma CK, Zarbo RJ, Frierson HF Jr, Lee MW. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 1993;99:551–557.

    PubMed  CAS  Google Scholar 

  90. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 1996;149:1167–1175.

    PubMed  CAS  Google Scholar 

  91. Fucich LF, Cheles MK, Thung SN, Gerber MA, Marrogi AJ. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994;118:927–930.

    PubMed  CAS  Google Scholar 

  92. Borscheri N, Roessner A, Rocken C. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol 2001;25:1297–1303.

    Article  PubMed  CAS  Google Scholar 

  93. Xiao S, Wang H, Hart J, Fleming D, Beard M. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 2001;159:1415–1421.

    PubMed  CAS  Google Scholar 

  94. Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988;12:187–197.

    PubMed  CAS  Google Scholar 

  95. Van Eyken P, Sciot R, Brock P, Casteels-Van Daele M, Ramaekers FC, Desmet VJ. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology 1990;17:101–107.

    Article  PubMed  Google Scholar 

  96. D’Errico A, Baccarini P, Fiorentino M, et al. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 1996;27:599–604.

    Article  PubMed  CAS  Google Scholar 

  97. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999;85:171–177.

    Article  PubMed  CAS  Google Scholar 

  98. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998;33:318–324.

    Article  PubMed  CAS  Google Scholar 

  99. Miskad U, Yano Y, Nakaji M, et al. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia. Pathol Int 2001;51:916–922.

    Article  PubMed  CAS  Google Scholar 

  100. Willuda J, Honegger A, Waibel R, et al. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 1999;59:5758–5767.

    PubMed  CAS  Google Scholar 

  101. Yabuuchi I, Kawata S, Tamura S, et al. Aromatase activity in human hepatocellular carcinoma. Relationship with the degree of histologic differentiation. Cancer 1993;71:56–61.

    Article  PubMed  CAS  Google Scholar 

  102. Volpes R, van den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 1993;142:1483–1492.

    PubMed  CAS  Google Scholar 

  103. Torii A, Nakayama A, Harada A, et al. Expression of the CD15 antigen in hepatocellular carcinoma. Cancer 1993;71:3864–3867.

    Article  PubMed  CAS  Google Scholar 

  104. Sciot R, Paterson AC, van Eyken P, Callea F, Kew MC, Desmet VJ. Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology 1988;12:53–63.

    Article  PubMed  CAS  Google Scholar 

  105. Haglund C, Lindgren J, Roberts PJ, Nordling S. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. Br J Cancer 1991;63:386–389.

    PubMed  CAS  Google Scholar 

  106. Nalesnik MA, Lee RG, Carr BI. Transforming growth factor alpha (TGFalpha) in hepatocellular carcinomas and adjacent hepatic parenchyma. Hum Pathol 1998;29:228–234.

    Article  PubMed  CAS  Google Scholar 

  107. Lamas E, Le Bail B, Housset C, Boucher O, Brechot C. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas. Lab Invest 1991;64:98–104.

    PubMed  CAS  Google Scholar 

  108. Ganjei P, Nadji M, Albores-Saavedra J, Morales AR. Histologic markers in primary and metastatic tumors of the liver. Cancer 1988;62:1994–1998.

    Article  PubMed  CAS  Google Scholar 

  109. Cohen C, Berson SD, Shulman G, Budgeon LR. Immunohistochemical ferritin in hepatocellular carcinoma. Cancer 1984;53:1931–1935.

    Article  PubMed  CAS  Google Scholar 

  110. Deprez C, Vangansbeke D, Fastrez R, Pasteels JL, Verhest A, Kiss R. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Am J Clin Pathol 1993;99:558–565.

    PubMed  CAS  Google Scholar 

  111. Erler BS, Hsu L, Truong HM, et al. Image analysis and diagnostic classification of hepatocellular carcinoma using neural networks and multivariate discriminant functions. Lab Invest 1994;71:446–451.

    PubMed  CAS  Google Scholar 

  112. Ochiai T, Urata Y, Yamano T, Yamagishi H, Ashihara T. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus. Hepatology 2000;31:615–621.

    Article  PubMed  CAS  Google Scholar 

  113. Wilkens L, Bredt M, Flemming P, Klempnauer J, Heinrich Kreipe H. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2000;192:43–51.

    Article  PubMed  CAS  Google Scholar 

  114. Kubo S, Nishiguchi S, Hirohashi K, et al. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn J Cancer Res 1998;89:419–426.

    PubMed  CAS  Google Scholar 

  115. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307–310.

    Article  PubMed  CAS  Google Scholar 

  116. Tannapfel A, Geissler F, Kockerling F, Katalinic A, Hauss J, Wittekind C. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathol 1999;187:439–445.

    Article  PubMed  CAS  Google Scholar 

  117. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 1995;76:399–405.

    Article  PubMed  CAS  Google Scholar 

  118. Ito Y, Matsuura N, Sakon M, et al. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer 1999;81:747–751.

    Article  PubMed  CAS  Google Scholar 

  119. Yamamoto K, Takenaka K, Kajiyama K, et al. Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma. Hepatogastroenterology 1999;46:813–819.

    PubMed  CAS  Google Scholar 

  120. Nakajima T, Moriguchi M, Mitsumoto Y, et al. Simple tumor profile chart based on cell kinetic parameters and histologic grade is useful for estimating the natural growth rate of hepatocellular carcinoma. Hum Pathol 2002;33:92–99.

    Article  PubMed  Google Scholar 

  121. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 1999;19:235–242.

    PubMed  CAS  Google Scholar 

  122. Ng IO. Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:666–670.

    PubMed  CAS  Google Scholar 

  123. Joo M, Kang YK, Kim MR, Lee HK, Jang JJ. Cyclin D1 overexpression in hepatocellular carcinoma. Liver 2001;21:89–95.

    Article  PubMed  CAS  Google Scholar 

  124. Huo TI, Wang XW, Forgues M, et al. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 2001;20:3620–3628.

    Article  PubMed  CAS  Google Scholar 

  125. Hui AM, Li X, Makuuchi M, Takayama T, Kubota K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999;84:604–608.

    Article  PubMed  CAS  Google Scholar 

  126. Jeng KS, Sheen IS, Chen BF, Wu JY. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg 2000;135:1329–1333.

    Article  PubMed  CAS  Google Scholar 

  127. Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 1998;18:555–564.

    PubMed  CAS  Google Scholar 

  128. Kondoh N, Wakatsuki T, Hada A, et al. Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 2001;18:1271–1278.

    PubMed  CAS  Google Scholar 

  129. Peng XM, Peng WW, Yao JL. Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol 1998;4:125–127.

    PubMed  CAS  Google Scholar 

  130. Shiota G, Kishimoto Y, Suyama A, et al. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol 1997;27:661–668.

    Article  PubMed  CAS  Google Scholar 

  131. Zhao M, Zimmermann A. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma. Histol Histopathol 1998;13:657–670.

    PubMed  CAS  Google Scholar 

  132. Azechi H, Nishida N, Fukuda Y, et al. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 2001;60:346–354.

    Article  PubMed  CAS  Google Scholar 

  133. Cohen C, DeRose PB. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol 1994;7:536–539.

    PubMed  CAS  Google Scholar 

  134. Hui AM, Makuuchi M. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand J Gastroenterol 1999;34:737–742.

    Article  PubMed  CAS  Google Scholar 

  135. Tannapfel A, Grund D, Katalinic A, et al. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer 2000;89:350–355.

    Article  PubMed  CAS  Google Scholar 

  136. Inagawa S, Itabashi M, Adachi S, et al. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 2002;8:450–456.

    PubMed  CAS  Google Scholar 

  137. Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, Tsuneyoshi M. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 2002;22:43–50.

    PubMed  CAS  Google Scholar 

  138. Yuen MF, Wu PC, Lai VC, Lau JY, Lai CL. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer 2001;91:106–112.

    Article  PubMed  CAS  Google Scholar 

  139. Kawate S, Fukusato T, Ohwada S, Watanuki A, Morishita Y. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression. Oncology 1999;57:157–163.

    Article  PubMed  CAS  Google Scholar 

  140. Miura N, Horikawa I, Nishimoto A, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997;93:56–62.

    Article  PubMed  CAS  Google Scholar 

  141. Nakashio R, Kitamoto M, Nakanishi T, Takaishi H, Takahashi S, Kajiyama G. [Telomere length and telomerase activity in hepatocellular carcinoma]. Nippon Rinsho 1998;56:1239–1243.

    PubMed  CAS  Google Scholar 

  142. Park Y, Choi J, Byun B, Cho C, Kim H, Kim B. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis. Exp Mol Med 1998;30:35–40.

    PubMed  CAS  Google Scholar 

  143. Sun BH, Zhang J, Wang BJ, et al. Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21 (WAF1) expression and hepatic apoptosis. World J Gastroenterol 2000;6:356–360.

    PubMed  CAS  Google Scholar 

  144. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999;19:287–296.

    PubMed  CAS  Google Scholar 

  145. Nakanuma Y, Terada T, Terasaki S, et al. ‘Atypical adenomatous hyperplasia’ in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Histopathology 1990;17:27–35.

    Article  PubMed  CAS  Google Scholar 

  146. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 1988;95:1664–1666.

    PubMed  CAS  Google Scholar 

  147. Farber E. Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Dig Dis Sci 1991;36:973–978.

    Article  PubMed  CAS  Google Scholar 

  148. Marsh JW, Dvorchik I, Subotin M, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997;26:444–450.

    Article  PubMed  CAS  Google Scholar 

  149. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;129:643–653.

    PubMed  CAS  Google Scholar 

  150. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990;50:5127–5135.

    PubMed  CAS  Google Scholar 

  151. Tannapfel A, Wittekind C. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch 2002;440:345–352.

    Article  PubMed  CAS  Google Scholar 

  152. Laurent-Puig P, Legoix P, Bluteau O, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763–1773.

    Article  PubMed  CAS  Google Scholar 

  153. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000;10:185–200.

    Article  PubMed  CAS  Google Scholar 

  154. Dumble ML, Croager EJ, Yeoh GC, Quail EA. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 2002;23:435–445.

    Article  PubMed  CAS  Google Scholar 

  155. Tarsetti F, Lenzi R, Salvi R, et al. Liver carcinogenesis associated with feeding of ethionine in a choline-free diet: evidence against a role of oval cells in the emergence of hepatocellular carcinoma. Hepatology 1993;18:596–603.

    PubMed  CAS  Google Scholar 

  156. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998;27:407–414.

    Article  PubMed  CAS  Google Scholar 

  157. Hsu HC, Wu TT, Sheu JC, et al. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology 1989;9:747–750.

    Article  PubMed  CAS  Google Scholar 

  158. Kawata A, Une Y, Hosokawa M, Uchino J, Kobayashi H. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma. Jpn J Clin Oncol 1992;22:256–263.

    PubMed  CAS  Google Scholar 

  159. Chedid A, Ryan LM, Dayal Y, Wolf BC, Falkson G. Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 1999;123:524–528.

    PubMed  CAS  Google Scholar 

  160. Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis. Cancer 1980;46:1448–1455.

    Article  PubMed  CAS  Google Scholar 

  161. Hoshino H, Katada N, Nishimura D, et al. Case report: fibrolamellar hepatocellular carcinoma in a Japanese woman’s case report and review of Japanese cases. J Gastroenterol Hepatol 1996;11:551–555.

    PubMed  CAS  Google Scholar 

  162. Yamaguchi R, Tajika T, Kanda H, Nakanishi K, Kawanishi J. Fibrolamellar carcinoma of the liver. Hepatogastroenterology 1999;46:1706–1709.

    PubMed  CAS  Google Scholar 

  163. Caballero T, Aneiros J, Lopez-Caballero J, Gomez-Morales M, Nogales F. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study. Histopathology 1985;9:445–456.

    Article  PubMed  CAS  Google Scholar 

  164. An T, Ghatak N, Kastner R, Kay S, Lee HM. Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 1983;79:392–396.

    PubMed  CAS  Google Scholar 

  165. Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S. Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 1983;51:97–100.

    Article  PubMed  CAS  Google Scholar 

  166. Cheuk W, Chan J. Clear cell variant of fibrolamellar carcinoma of the liver. Arch Pathol Lab Med 2001;125:1235–1238.

    PubMed  CAS  Google Scholar 

  167. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784–794.

    Article  PubMed  CAS  Google Scholar 

  168. Okano A, Hajiro K, Takakuwa H, Kobashi Y. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report. Am J Gastroenterol 1998;93:1144,1145.

    Article  PubMed  CAS  Google Scholar 

  169. Nerlich AG, Majewski S, Hunzelmann N, et al. Excessive collagen formation in fibrolamellar carcinoma of the liver: a morphological and biochemical study. Mod Pathol 1992;5:580–585.

    PubMed  CAS  Google Scholar 

  170. Orsatti G, Hytiroglou P, Thung SN, Ishak KG, Paronetto F. Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver 1997;17:152–156.

    PubMed  CAS  Google Scholar 

  171. Saul SH, Titelbaum DS, Gansler TS, et al. The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer 1987;60:3049–3055.

    Article  PubMed  CAS  Google Scholar 

  172. Hemming AW, Langer B, Sheiner P, Greig PD, Taylor BR. Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J Gastrointest Surg 1997;1:342–346.

    Article  PubMed  CAS  Google Scholar 

  173. Zografos GN, Palmer S, Papastratis G, Habib NA. Aggressive surgical management of fibrolamellar hepatocellular carcinoma in puberty. Eur J Surg Oncol 1997;23:570–572.

    Article  PubMed  CAS  Google Scholar 

  174. Starzl TE, Iwatsuki S, Shaw BW Jr, Nalesnik MA, Farhi DC, Van Thiel DH. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986;162:145–148.

    PubMed  CAS  Google Scholar 

  175. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997;26:877–883.

    Article  PubMed  CAS  Google Scholar 

  176. Wu PC, Lai CL, Lam KC, Lok AS, Lin HJ. Clear cell carcinoma of liver. An ultrastructural study. Cancer 1983;52:504–507.

    Article  PubMed  CAS  Google Scholar 

  177. Sasaki K, Okuda S, Takahashi M, Sasaki M. Hepatic clear cell carcinoma associated with hypoglycemia and hypercholesterolemia. Cancer 1981;47:820–822.

    Article  PubMed  CAS  Google Scholar 

  178. Emile J, Lemoine A, Azoulay D, Debuire B, Bismuth H, Reynes M. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology 2001;38:225–231.

    Article  PubMed  CAS  Google Scholar 

  179. Orsatti G, Arnold MM, Paronetto F. DNA image cytometric analysis of primary clear cell carcinoma of the liver. Arch Pathol Lab Med 1994;118:1226–1229.

    PubMed  CAS  Google Scholar 

  180. Murakata LA, Ishak KG, Nzeako UC. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000;13:874–881.

    Article  PubMed  CAS  Google Scholar 

  181. Okuda K. Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 1997;12:S314–S318.

    PubMed  CAS  Google Scholar 

  182. Albar JP, De Miguel F, Esbrit P, Miranda R, Fernandez-Flores A, Sarasa JL. Immunohistochemical detection of parathyroid hormone-related protein in a rare variant of hepatic neoplasm (sclerosing hepatic carcinoma). Hum Pathol 1996;27:728–731.

    Article  PubMed  CAS  Google Scholar 

  183. Yamashita Y, Fan ZM, Yamamoto H, et al. Sclerosing hepatocellular carcinoma: radiologic findings. Abdom Imaging 1993;18:347–351.

    Article  PubMed  CAS  Google Scholar 

  184. Omata M, Peters RL, Tatter D. Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1981;1:33–49.

    PubMed  CAS  Google Scholar 

  185. Papotti M, Sambataro D, Marchesa P, Negro F. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features. Liver 1997;17:47–52.

    PubMed  CAS  Google Scholar 

  186. Gil-Benso R, Martinez-Lorente A, Pellin-Perez A, et al. Characterization of a new rat cell line established from 2’ AAF-induced combined hepatocellular cholangiocellular carcinoma. In Vitro Cell Dev Biol Anim 2001;37:17–25.

    Article  PubMed  CAS  Google Scholar 

  187. Akasofu M, Kawahara E, Kaji K, Nakanishi I. Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver. Virchows Arch 1999;434:511–515.

    Article  PubMed  CAS  Google Scholar 

  188. Sasaki A, Yokoyama S, Nakayama I, Nakashima K, Kim YI, Kitano S. Sarcomatoid hepatocellular carcinoma with osteoclast-like giant cells: case report and immunohistochemical observations. Pathol Int 1997;47:318–324.

    PubMed  CAS  Google Scholar 

  189. Leger-Ravet MB, Borgonovo G, Amato A, Lemaigre G, Franco D. Carcinosarcoma of the liver with mesenchymal differentiation: a case report. Hepatogastroenterology 1996;43:255–259.

    PubMed  CAS  Google Scholar 

  190. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 1991;68:93–97.

    Article  PubMed  CAS  Google Scholar 

  191. Kim D, Park S, Kim H, Chun Y, Moon W, Park S. A comprehensive karyotypic analysis on a newly established sarcomatoid hepatocellular carcinoma cell line SH-J1 by comparative genomic hybridization and chromosome painting. Cancer Genet Cytogenet 2002;132:120–124.

    Article  PubMed  CAS  Google Scholar 

  192. Bortolasi L, Marchiori L, Dal Dosso I, Colombari R, Nicoli N. Hepatoblastoma in adult age: a report of two cases. Hepatogastroenterology 1996;43:1073–1078.

    PubMed  CAS  Google Scholar 

  193. Altmann HW. Epithelial and mixed hepatoblastoma in the adult. Histological observations and general considerations. Pathol Res Pract 1992;188:16–26.

    PubMed  CAS  Google Scholar 

  194. Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967;20:396–422.

    Article  PubMed  CAS  Google Scholar 

  195. Ito E, Sato Y, Kawauchi K, et al. Type 1a glycogen storage disease with hepatoblastoma in siblings. Cancer 1987;59:1776–1780.

    Article  PubMed  CAS  Google Scholar 

  196. Giardiello FM, Offerhaus GJ, Krush AJ, et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991;119:766–768.

    Article  PubMed  CAS  Google Scholar 

  197. Lynch HT, Thorson AG, McComb RD, Franklin BA, Tinley ST, Lynch JF. Familial adenomatous polyposis and extracolonic cancer. Dig Dis Sci 2001;46:2325–2332.

    Article  PubMed  CAS  Google Scholar 

  198. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol 1983;14:512–537.

    Article  PubMed  CAS  Google Scholar 

  199. Stocker JT. Hepatoblastoma. Semin Diagn Pathol 1994;11:136–143.

    PubMed  CAS  Google Scholar 

  200. Ding SF, Michail NE, Habib NA. Genetic changes in hepatoblastoma. J Hepatol 1994;20:672–675.

    Article  PubMed  CAS  Google Scholar 

  201. Tsuchida Y, Ikeda H, Suzuki N, et al. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein. J Pediatr Surg 1999;34:1762–1764.

    Article  PubMed  CAS  Google Scholar 

  202. Watanabe I, Yamaguchi M, Kasai M. Histologic characteristics of gonadotropin-producing hepatoblastoma: a survey of seven cases from Japan. J Pediatr Surg 1987;22:406–411.

    Article  PubMed  CAS  Google Scholar 

  203. Conran RM, Hitchcock CL, Waclawiw MA, Stocker JT, Ishak KG. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 1992;12:167–183.

    PubMed  CAS  Google Scholar 

  204. Joshi VV, Kaur P, Ryan B, Saad S, Walters TR. Mucoid anaplastic hepatoblastoma. A case report. Cancer 1984;54:2035–2039.

    Article  PubMed  CAS  Google Scholar 

  205. Sola Perez J, Perez-Guillermo M, Bas Bernal AB, Mercader JM. Hepatoblastoma. An attempt to apply histologic classification to aspirates obtained by fine needle aspiration cytology. Acta Cytol 1994;38:175–182.

    PubMed  CAS  Google Scholar 

  206. Pollice L, Zito FA, Troia M. Hepatoblastoma: a clinico-pathologic review. Pathologica 1992;84:25–32.

    PubMed  CAS  Google Scholar 

  207. Ruck P, Harms D, Kaiserling E. Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation. Am J Surg Pathol 1990;14:847–855.

    PubMed  CAS  Google Scholar 

  208. Kasai M, Watanabe I. Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan. Cancer 1970;25:551–563.

    Article  PubMed  CAS  Google Scholar 

  209. Gonzalez-Crussi F. Undifferentiated small cell (“anaplastic”) hepatoblastoma. Pediatr Pathol 1991;11:155–161.

    PubMed  CAS  Google Scholar 

  210. Lack EE, Neave C, Vawter GF. Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 1982;6:693–705.

    Article  PubMed  CAS  Google Scholar 

  211. Emura I, Ohnishi Y, Yamashita Y, Iwafuchi M. Immunohistochemical and ultrastructural study on erythropoiesis in hepatoblastoma. Acta Pathol Jpn 1985;35:79–86.

    PubMed  CAS  Google Scholar 

  212. Gonzalez-Crussi F, Upton MP, Maurer HS. Hepatoblastoma. Attempt at characterization of histologic subtypes. Am J Surg Pathol 1982;6:599–612.

    Article  PubMed  CAS  Google Scholar 

  213. Manivel C, Wick MR, Abenoza P, Dehner LP. Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood. Cancer 1986;57:2168–2174.

    Article  PubMed  CAS  Google Scholar 

  214. Morinaga S, Yamaguchi M, Watanabe I, Kasai M, Ojima M, Sasano N. An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin. Cancer 1983;51:1647–1652.

    Article  PubMed  CAS  Google Scholar 

  215. Abenoza P, Manivel JC, Wick MR, Hagen K, Dehner LP. Hepatoblastoma: an immunohistochemical and ultrastructural study. Hum Pathol 1987;18:1025–1035.

    Article  PubMed  CAS  Google Scholar 

  216. Tagge EP, Tagge DU, Reyes J, et al. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992;27:292–296; discussion, 297.

    Article  PubMed  CAS  Google Scholar 

  217. Filler RM, Ehrlich PF, Greenberg ML, Babyn PS. Preoperative chemotherapy in hepatoblastoma. Surgery 1991;110:591–596; discussion, 596,597.

    PubMed  CAS  Google Scholar 

  218. Saxena R, Leake JL, Shafford EA, et al. Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 1993;17:1266–1271.

    Article  PubMed  CAS  Google Scholar 

  219. Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989;64:1082–1095.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology Department, Inonu University, Malatya, Turkey

    Hale Kirimlioglu MD

  2. Division of Transplantation and Hepatic Pathology, Department of Pathology, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA

    Anthony J. Demetris MD & Michael A. Nalesnik MD

Authors
  1. Hale Kirimlioglu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony J. Demetris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael A. Nalesnik MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Liver Cancer Center, Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA

    Brian I. Carr MD, FRCP, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Kirimlioglu, H., Demetris, A.J., Nalesnik, M.A. (2005). Pathological Aspects of Hepatocellular Tumors. In: Carr, B.I. (eds) Hepatocellular Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-844-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-844-1_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-125-7

  • Online ISBN: 978-1-59259-844-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation